Show simple item record

How did the 2003 prescription drug re-importation bill pass the house?

dc.contributor.author Gokcekus, O
dc.contributor.author Adams, M
dc.contributor.author Grabowski, H
dc.contributor.author Tower, E
dc.date.accessioned 2013-04-23T17:01:34Z
dc.date.issued 2006-03-01
dc.identifier.issn 0954-1985
dc.identifier.uri https://hdl.handle.net/10161/6724
dc.description.abstract We examine the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: Contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies - employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: Party affiliation was the most important factor in passing the bill. © 2006 The Authors. Journal compilation © 2006 Blackwell Publishing Ltd.
dc.publisher Wiley
dc.relation.ispartof Economics and Politics
dc.relation.isversionof 10.1111/j.1468-0343.2006.00161.x
dc.title How did the 2003 prescription drug re-importation bill pass the house?
dc.type Journal article
duke.contributor.id Grabowski, H|0099498
duke.contributor.id Tower, E|0096168
pubs.begin-page 27
pubs.end-page 45
pubs.issue 1
pubs.organisational-group Duke
pubs.organisational-group Economics
pubs.organisational-group Trinity College of Arts & Sciences
pubs.publication-status Published
pubs.volume 18
dc.identifier.eissn 1468-0343


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record